We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies on the site. Please see our Privacy Policy for details.

Team Experience Thought Leadership About Press Room Locations Careers
Related Sites
MWE China Law Offices McDermott+Consulting
MENU McDermott Will & Emery
Languages
Deutsch English Français Italiano
McDermott Will & Emery
Team Experience Thought
Leadership
About Press
Room
Locations Careers
Languages
Deutsch English Français Italiano

Thought Leadership

Connect Share Print your pages
  • {{page.name}}
  • Linked In
    Linked In
  • Xing
    Xing
  • Twitter
    Twitter
  • Facebook
    Facebook
  • Email This
    Email This
  • Summary
  • Explore More

WEBCAST: The Wait is Over — Now What? Steps to Respond to the Proposed 340B Omnibus Guidance

September 16, 2015 Webcast

Summary

2:30 – 3:30 pm EDT

To view the archived presentation, please click here.
HHS Releases Long-Awaited 340B Proposed Guidance, On the Subject

On August 27, 2015, the U.S. Department of Health and Human Services (HHS) released the long-awaited and much-anticipated proposed 340B Drug Pricing Program (340B Program) Omnibus Guidance (Proposed Guidance). The Proposed Guidance addresses most of those 340B Program eligibility and compliance requirements that are not subject to HHS formal rulemaking authority.

The impact of the Proposed Guidance includes the following:
  • Significantly revised definitions of
    • Drugs eligible for discounted 340B prices and
    • Patients eligible to receive such discounts
  • Future alterations including compliance with the group purchasing organization (GPO) prohibition, contracts with governmental entities to support 340B Program eligibility, auditable records requirements, dispensing of 340B drugs to Medicaid managed care enrollees, and contract pharmacy oversight, among other topics 
McDermott Will & Emery invites you to attend this complimentary webcast, which will highlight key takeaways of the Proposed Guidance. Health care providers participating in the 340B Program will learn how the Proposed Guidance could impact common current 340B Program practices and should not miss this program!

The webcast will focus on the implications to the 340B Program if the Proposed Guidance is implemented as proposed and how to respond to the Proposed Guidance. 

McDermott Speakers

Emily J. Cook, Partner
David S. Ivill, Partner
Joseph M. Parise, Associate

Moderator

Jason B. Caron, Partner

For more information, please contact McDermott Events.

CLE credit for the live presentation of this program is pending in the following states: California, Illinois, New York and Texas. A Uniform Certificate of Attendance will be made available to participants requesting CLE credit in all other states. Please be advised that CLE credit will not be approved for on demand/recorded viewings of this program in the states listed above. Attendees seeking credit in other states should consult their state CLE accrediting agency to determine whether self-study credit can be earned for on demand/recorded viewing of this program.

Find More Publications & Events
Health

Get In Touch

  • Caron, Jason B.

    Jason B. Caron

    Partner Washington, DC
  • Cook, Emily J.

    Emily J. Cook

    Partner Los Angeles
  • Ivill David

    David S. Ivill

    Partner New York
  • Parise Joseph

    Joseph M. Parise

    Associate New York

Related Experience

  • Health

© 2018 McDermott Will & Emery

Legal Notices Imprint Privacy and Cookies Policy Client Connect Connect@McDermott Contact Us
Related Sites MWE China Law Offices McDermott+Consulting
Attorney Advertising